English  |  正體中文  |  简体中文  |  2832010  
???header.visitor??? :  33615115    ???header.onlineuser??? :  1058
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"tseng t c"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 41-65 of 534  (22 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-01-25T03:25:06Z Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy Su T.-H.; Yang H.-C.; Tseng T.-C.; Liou J.-M.; Liu C.-H.; CHI-LING CHEN; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏 2022-01-25T03:25:04Z Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; CHI-LING CHEN; Kao J.-H.
臺大學術典藏 2022-01-25T03:25:04Z Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; CHI-LING CHEN; Kao J.-H.
臺大學術典藏 2022-01-25T03:25:03Z Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; Liu C.-H.; Liu C.-J.; CHI-LING CHEN; Kao J.-H.
臺大學術典藏 2022-01-25T03:25:03Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Su T.-H.; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; CHI-LING CHEN; Adhoute X.; Bourli?re M.; Kao J.-H.
臺大學術典藏 2022-01-25T03:25:02Z High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; CHI-LING CHEN; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T03:25:01Z HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis Tseng T.-C.; Liu C.-J.; Chang C.T.; Su T.-H.; Yang W.-T.; Tsai C.-H.; CHI-LING CHEN; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T03:25:01Z Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; CHI-LING CHEN; Kao J.-H.
臺大學術典藏 2022-01-25T03:24:58Z Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis Su T.-H.; Peng C.-Y.; Chang S.-H.; Tseng T.-C.; Liu C.-J.; CHI-LING CHEN; Liu C.-H.; Yang H.-C.; Chen P.-J.; Kao J.-H.
臺大學術典藏 2022-01-25T03:24:57Z Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; CHI-LING CHEN; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; Kao J.-H.
臺大學術典藏 2022-01-24T09:32:12Z Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan Tseng T.-C.; CHUN-JEN LIU; Chen P.-J.; Lai M.-Y.; Lin C.-L.; Kao J.-K.; Chen D.-S.
臺大學術典藏 2022-01-24T09:32:11Z Sequential combination therapy for chronic hepatitis B: More challenges to be tackled [7] Tseng T.-C.; CHUN-JEN LIU; Kao J.-H.
臺大學術典藏 2022-01-24T09:32:07Z A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients Tseng T.-C.; CHUN-JEN LIU; Wang C.-C.; Chen P.-J.; Lai M.-Y.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2022-01-24T09:32:06Z Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial Liu C.-H.; CHUN-JEN LIU; Lin C.-.; Liang C.-C.; Hsu S.-J.; Yang S.-S.; Hsu C.-S.; Tseng T.-C.; Wang C.-C.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:32:05Z Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels Tseng T.-C.; CHUN-JEN LIU; Wang C.-C.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:32:04Z Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C Hsieh T.-H.; Tseng T.-C.; CHUN-JEN LIU; Lai M.-Y.; Chen P.-J.; Hsieh H.-L.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:32:01Z Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy Tseng T.-C.; CHUN-JEN LIU; Hsieh S.-C.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:59Z Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection Hsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; Tseng T.-C.; Chen C.-H.; Su W.-C.; CHUN-JEN LIU; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:59Z Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B Su T.-H.; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; CHUN-JEN LIU; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:57Z Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy Tseng T.-C.; Yu M.-L.; CHUN-JEN LIU; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:57Z Implications of hepatitis B virus genomic variations on treatment outcomes Tseng T.-C.; CHUN-JEN LIU; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:55Z Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Tseng T.-C.; Liu C.-H.; Niu W.-F.; Jeng J.; CHUN-JEN LIU; Lai M.-Y.; Chen P.-J.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2022-01-24T09:31:55Z Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: Genotype B vs C CHUN-JEN LIU; Cheng H.-R.; Chen C.-L.; Chen T.-C.; Tseng T.-C.; Wang Z.-L.; Chen P.-J.; Liu C.-H.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:53Z Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters Tseng T.-C.; CHUN-JEN LIU; Chen C.-L.; Wang C.-C.; Su T.-H.; Kuo S.F.-T.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:53Z High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load Tseng T.-C.; CHUN-JEN LIU; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.

Showing items 41-65 of 534  (22 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page